Saturday, September 21 - Tuesday, September 24, 2019
Sheraton Grand Seattle Hotel
This four-day program will cover data supporting guidelines, recommendations and recent advances regarding
therapeutic options for patients with solid tumors and hematologic disorders. At the end of the course, physicians
will leave with a comprehensive syllabus, a self-assessment and a deeper understanding of the pathogenesis,
diagnostic evaluation and therapeutic modalities available for a breadth of solid tumors as well as hematologic
disorders. There will be a case-based review session and discussions.
Learn more and register